News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.
Featured News Item
R3 Seminar Recap: Using RECOVER biosamples to advance your research
On January 13, 2026, RECOVER hosted the second webinar in its 2-part series to help prospective researchers use biosamples from the initiative’s observational studies. RECOVER has made over 1.4 million biosamples available for study across the human lifespan, including 24,000 samples from its tissue pathology (autopsy) study. This webinar is part of the RECOVER Research Review (R3) Seminar Series, which brings the scientific community together to accelerate diagnosing, preventing, and treating Long COVID.
R3 Seminar Recap
148 Results
148 Results
Task force makes recommendations for studying biological systems as part of Long COVID research
Combining knowledge across different scientific specialties that study biological systems could reveal information that improves the diagnosis of Long COVID and supports the development of personalized Long COVID treatments.
Feature
RECOVER study highlights variations in Long COVID symptoms among children of different backgrounds
RECOVER researchers studied health records to understand how racial and ethnic backgrounds may impact pediatric Long COVID symptoms. These findings could support early detection and management of Long COVID symptoms for all children.
Feature
R3 Seminar Recap: Effectiveness of Paxlovid in Protecting Against Long COVID: EHR Insights
During the April 8th RECOVER Research Review (R3) Seminar, RECOVER researchers Hannah Mandel, MS, Fei Wang, PhD, Sandy Preiss, MS, and Abhishek Bhatia, MS presented findings from two different studies of electronic health records (EHRs). Rainu Kaushal, MD (Cornell University), Dr. Wang’s co-author, joined the presenters for the panel discussion and audience Q&A. Both studies examined whether taking the antiviral drug Paxlovid during a COVID-19 infection could help prevent Long COVID. Although Paxlovid is known to reduce the risk of severe COVID-19, there has been limited research into how Paxlovid might impact a person’s risk of developing Long COVID. The studies presented are two of the largest to date that have explored the role of Paxlovid in Long COVID prevention.
R3 Seminar Recap
RECOVER Representatives help inform and raise awareness about RECOVER research
Patient, Caregiver, and Community Representatives inform RECOVER research, help connect the initiative with different communities, and share news about RECOVER studies.
Feature
R3 Seminar Recap: Sex Differences in Long COVID
During the March 11th RECOVER Research Review (R3) Seminar, RECOVER researchers shared findings from a recent study that examined how a person’s sex may affect their risk of developing Long COVID. Dimpy Shah, MD, PhD (University of Texas Health Science Center) presented results from the study, and Nora Singer, MD (Case Western Reserve University, MetroHealth Medical Center) shared background about RECOVER’s adult observational study population and ideas for future research in this area.
R3 Seminar Recap
R3 Seminar Recap: Characterization of PASC and investigation of biomarkers: Insights from the RECOVER adult cohort
During the February 11th RECOVER Research Review (R3) Seminar, Dr. Grace McComsey (Case Western Reserve University) and Dr. Kristine Erlandson (University of Colorado Anschutz Medical Campus) discussed how biomarkers – signs of disease that can be observed and measured – may provide information that will improve researchers’ ability to understand, diagnose, prevent, and treat Long COVID. Dr. McComsey and Dr. Linda Geng (Stanford University) also discussed recent updates to and findings from the RECOVER-Adult Long COVID Research Index.
R3 Seminar Recap
RECOVER study examines how a person’s sex impacts Long COVID risk
A recent RECOVER study found that women had a 31% higher risk for developing Long COVID than men. Findings from this study may help identify who is at a higher risk for developing Long COVID and potential Long COVID treatments.
Feature
RECOVER Representatives inform Long COVID research through authorship
Over the last two years, RECOVER Patient, Caregiver, and Community Representatives have helped plan and write more than 100 publications about RECOVER’s Long COVID research and its findings.
Feature